Breast Cancer Awareness in 2008

Thanks for your note. As you probably know, we haven't identified a receptor or a biomarker to identify people with triple-negative disease; they're identified by the absence of hormone receptors and HER-2. But lots of research is being done to characterize triple-negative breast cancer biologically, and figure out what treatments work best for them. The best place to start reviewing research is Pubmed at http://www.ncbi.nlm.nih.gov/sites/entrez/. The best place to find clinical trials is http://www.clinicaltrials.gov. The FDA website also has information on clinical trials at http://www.fda.gov/oashi/clinicaltrials/default.htm.

Results from govenment funded research are supposed to be published and available free to the public. But not all journals make that happen, and phamaceutical companies often neglect to publish negative findings, so it can be difficult to assess the weight of the evidence when you're not really looking at all of it.

Good luck.

I know research is going on at M.D. Anderson in Houston on triple negative.  But to date, no trials that I have heard of.  I appreciate your time in replying to my question.  Keep up the wonderful, honorable work that you do!